CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Calendar Charles River Laboratories International, Inc.

Stocks

CRL

US1598641074

Biotechnology & Medical Research

Market Closed - NYSE 21:00:03 06/11/2026 GMT			5-day change	1st Jan Change
337.52 ^USD	+7.83%		-6.09%	+69.20%

11-05	UBS Adjusts Price Target on Charles River Laboratories International to $387 From $357, Maintains Buy Rating	MT
11-05	Rothschild & Co Redburn Adjusts Price Target on Charles River Laboratories International to $375 From $318	MT

Chart calendar Charles River Laboratories International, Inc.

2981bc72568b4875.b7RIZUCn4N4dX3olGRj-VEVZdMyWyHXThj9ZT-JMZQU.LYcfURHG2bBXbDlmbVurIBQ_HLXZmAypsxIxPs8mBn0w5SoQct6nqUQ2Iw~85cab5d39f91bd9615076d9a8e508fb3

Upcoming events on Charles River Laboratories International, Inc.

No events available

Past events on Charles River Laboratories International, Inc.

04/11/2026	Earnings release - Q3 2026
04/11/2026	Earnings presentation	14:00
24/09/2026	Analyst/Investor Day	14:00
05/08/2026	Earnings presentation	14:00
05/08/2026	Earnings release - Q2 2026
07/05/2026	Earnings presentation	13:30
07/05/2026	Earnings release - Q1 2026
05/05/2026	Annual General Meeting	13:00
18/02/2026	Earnings release - Q4 2025
18/02/2026	Earnings presentation	13:30

Annual results

Fiscal Period	December	2023	2024	2025	2026	2027	2028
Net sales Million USD	Released Forecast Spread	4 129 4 107 0.54%	4 050 4 031 0.47%	4 015 4 006 0.23%	3 956	4 038	4 270
EBITDA Million USD	Released Forecast Spread	1 013 1 017 -0.4%	996 998 -0.19%	972 966 0.56%	1 033	1 118	1 192
EBIT Million USD	Released Forecast Spread	839 842 -0.35%	806 802 0.46%	794 794 0.01%	829	929	1 022
Earnings before Tax (EBT) Million USD	Released Forecast Spread	581 513 13.41%	93,1 401 -76.8%	-99,5 312 -131.9%	309	551	635
Net income Million USD	Released Forecast Spread	475 387 22.66%	10,3 301 -96.58%	-144 215 -167.17%	187	437	489
EPS USD	Released Forecast Spread	9,22 7,49 23.07%	0,20 5,83 -96.57%	-2,91 4,19 -169.42%	3,85	9,05	10,2
Announcement Date		14/02/24	19/02/25	18/02/26	-

Quarterly results

Fiscal Period	September	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3	2027 Q4	2028 Q1	2028 Q2	2028 Q3
Net sales Million USD	Released Forecast Spread	984 942 4.48%	1 032 990 4.3%	1 005 991 1.42%	994 987 0.73%	996 979 1.67%	1 004 977 2.75%	983 960 2.33%	973	983	1 015	1 013	1 010	1 015	1 051	1 052
EBITDA Million USD	Released Forecast Spread	232 216 7.35%	272 248 10.07%	243 231 4.98%	225 225 -0.14%	204 199 2.28%	245 248 -1.09%	266 266 0.05%	286	259	272	280	287	267	285	296
EBIT Million USD	Released Forecast Spread	188 169 11.54%	228 194 17.86%	198 186 6.32%	180 180 0.01%	163 153 6.5%	206 202 1.59%	226 217 3.98%	239	208	224	228	246	226	249	253
Earnings before Tax (EBT) Million USD	Released Forecast Spread							171 127 34.63%	155	125	137	139	169
Net income Million USD	Released Forecast Spread	25,5 45,3 -43.75%		54,4 58,7 -7.21%	-277 68,3 -505.08%	-14,8 35,8 -141.47%	-1,48 91,9 -101.61%	333 86,1 286.71%	100	102	115	117	136	105	123	126
EPS USD	Released Forecast Spread	0,50 0,97 -48.45%	1,06 1,38 -23.19%	1,10 1,45 -23.96%	-5,62 1,35 -515.27%	-0,30 0,91 -133.15%	-0,03 2,03 -101.48%	6,86 1,99 244.15%	1,95	2,10	2,37	2,42	2,82	2,23	2,62	2,69
Announcement Date		07/05/25	06/08/25	05/11/25	18/02/26	07/05/26	05/08/26	04/11/26	-	-	-	-	-	-	-	-

Upcoming sector events for Charles River Laboratories International, Inc.

09/11/2026	PRAXIS PRECISION MEDICINES, INC.	Earnings release - Q3 2026
09/11/2026	IONIS PHARMACEUTICALS, INC.	Earnings release - Q3 2026
09/11/2026	IONIS PHARMACEUTICALS, INC.	Earnings presentation	14:00
09/11/2026	IMMUNOVANT, INC.	Earnings release - Q2 2027
09/11/2026	IMMUNOVANT, INC.	Earnings presentation	13:00
09/11/2026	DEFINIUM THERAPEUTICS, INC.	Earnings presentation	21:30
09/11/2026	DEFINIUM THERAPEUTICS, INC.	Earnings release - Q3 2026
09/11/2026	ABCELLERA BIOLOGICS INC.	Earnings release - Q3 2026
09/11/2026	ABCELLERA BIOLOGICS INC.	Earnings presentation	22:00
09/11/2026	VIRIDIAN THERAPEUTICS, INC.	Information meeting	13:00

Past sector events for Charles River Laboratories International, Inc.

06/11/2026	QIAGEN N.V.	Extraordinary General Meeting
06/11/2026	QIAGEN N.V.	Présentation aux Actionnaires / Analystes	13:00
06/11/2026	BRAVEHEART BIO, INC.	Présentation aux Actionnaires / Analystes	21:35
06/11/2026	SHOUYAO HOLDINGS (BEIJING) CO., LTD.	Earnings presentation	07:00
05/11/2026	BEONE MEDICINES AG	Earnings presentation	13:00
05/11/2026	BEONE MEDICINES AG	Earnings release - Q3 2026
05/11/2026	JOINN LABORATORIES(CHINA)CO.,LTD.	Earnings presentation	01:00
05/11/2026	RUBICON RESEARCH LIMITED	Earnings release - Q2 2027
05/11/2026	RUBICON RESEARCH LIMITED	Board of Directors Meeting
05/11/2026	RUBICON RESEARCH LIMITED	Earnings presentation	12:00

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Charles River Laboratories International, Inc.

Net sales - Rate of surprise

Rate of surprise - Net sales - Annual - Charles River Laboratories International, Inc.

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Charles River Laboratories International, Inc.

Stock Market
Stocks
CRL Stock
Calendar Charles River Laboratories International, Inc.

As early as today, start finding the best investment opportunities!